eSight is digital eyewear that enables the visually impaired to actually see and is currently recommended for those with visual acuity between 20/60 and 20/400.
Imagistx has developed an ultra high-resolution ultrasound system that provides significant improvements in detecting prostate cancer (as per initial Clinical Study by Johns Hopkins). The system [...]
Rna Diagnostics has developed a molecular diagnostic technology that radically improves cancer chemotherapy management.
Half of all breast cancer patients receive chemotherapy. Yet, less than [...]
BrainFx Inc. creates digital clinical assessment tools to measure the effects of mild to moderate brain disorders (brain injury, mental illness or neurodegenerative) on real world function. [...]
Contact Us
If you’re interested in learning more about angel investing, please contact us.
